Neurocognitive  ||| S:0 E:15 ||| JJ
deficit  ||| S:15 E:23 ||| NN
changes  ||| S:23 E:31 ||| NNS
in  ||| S:31 E:34 ||| IN
relation  ||| S:34 E:43 ||| NN
to  ||| S:43 E:46 ||| TO
the  ||| S:46 E:50 ||| DT
course  ||| S:50 E:57 ||| NN
of  ||| S:57 E:60 ||| IN
schizophrenia  ||| S:60 E:74 ||| NN
and  ||| S:74 E:78 ||| CC
schizophrenia  ||| S:78 E:92 ||| JJ
spectrum  ||| S:92 E:101 ||| NN
disorders ||| S:101 E:110 ||| NNS
:  ||| S:110 E:112 ||| :
5-year  ||| S:112 E:119 ||| CD
follow-up  ||| S:119 E:129 ||| JJ
study  ||| S:129 E:135 ||| NN
Cognitive  ||| S:135 E:145 ||| NNP
deficit  ||| S:145 E:153 ||| NN
is  ||| S:153 E:156 ||| VBZ
present  ||| S:156 E:164 ||| JJ
in  ||| S:164 E:167 ||| IN
most  ||| S:167 E:172 ||| JJS
of  ||| S:172 E:175 ||| IN
schizophrenia  ||| S:175 E:189 ||| JJ
cases  ||| S:189 E:195 ||| NNS
and  ||| S:195 E:199 ||| CC
even  ||| S:199 E:204 ||| RB
better  ||| S:204 E:211 ||| RB
explains  ||| S:211 E:220 ||| VBZ
functional  ||| S:220 E:231 ||| JJ
outcomes  ||| S:231 E:240 ||| NNS
then  ||| S:240 E:245 ||| RB
positive  ||| S:245 E:254 ||| JJ
and  ||| S:254 E:258 ||| CC
negative  ||| S:258 E:267 ||| JJ
symptoms ||| S:267 E:275 ||| NNS
.  ||| S:275 E:277 ||| .
There  ||| S:277 E:283 ||| EX
have  ||| S:283 E:288 ||| VBP
been  ||| S:288 E:293 ||| VBN
less  ||| S:293 E:298 ||| JJR
consensus  ||| S:298 E:308 ||| NN
regarding  ||| S:308 E:318 ||| VBG
the  ||| S:318 E:322 ||| DT
long-term  ||| S:322 E:332 ||| JJ
course  ||| S:332 E:339 ||| NN
of  ||| S:339 E:342 ||| IN
cognitive  ||| S:342 E:352 ||| JJ
functioning  ||| S:352 E:364 ||| NN
after  ||| S:364 E:370 ||| IN
onset  ||| S:370 E:376 ||| NN
of  ||| S:376 E:379 ||| IN
the  ||| S:379 E:383 ||| DT
illness ||| S:383 E:390 ||| NN
.  ||| S:390 E:392 ||| .
In  ||| S:392 E:395 ||| IN
our  ||| S:395 E:399 ||| PRP$
study  ||| S:399 E:405 ||| NN
we  ||| S:405 E:408 ||| PRP
used  ||| S:408 E:413 ||| VBD
a  ||| S:413 E:415 ||| DT
neuropsychological  ||| S:415 E:434 ||| JJ
test  ||| S:434 E:439 ||| NN
battery  ||| S:439 E:447 ||| NN
based  ||| S:447 E:453 ||| VBN
on  ||| S:453 E:456 ||| IN
Luria`s  ||| S:456 E:464 ||| CD
systematic  ||| S:464 E:475 ||| JJ
approach  ||| S:475 E:484 ||| NN
in  ||| S:484 E:487 ||| IN
testing  ||| S:487 E:495 ||| NN
of  ||| S:495 E:498 ||| IN
patients  ||| S:498 E:507 ||| NNS
at  ||| S:507 E:510 ||| IN
their  ||| S:510 E:516 ||| PRP$
first  ||| S:516 E:522 ||| JJ
episode  ||| S:522 E:530 ||| NN
of  ||| S:530 E:533 ||| IN
schizophrenia  ||| S:533 E:547 ||| NN
and  ||| S:547 E:551 ||| CC
schizophrenia  ||| S:551 E:565 ||| JJ
spectrum  ||| S:565 E:574 ||| NN
disorders  ||| S:574 E:584 ||| NNS
and  ||| S:584 E:588 ||| CC
during  ||| S:588 E:595 ||| IN
5-year  ||| S:595 E:602 ||| NNP
follow-up ||| S:602 E:611 ||| NNP
.  ||| S:611 E:613 ||| .
The  ||| S:613 E:617 ||| DT
results  ||| S:617 E:625 ||| NNS
indicated  ||| S:625 E:635 ||| VBD
that  ||| S:635 E:640 ||| IN
patients  ||| S:640 E:649 ||| NNS
with  ||| S:649 E:654 ||| IN
various  ||| S:654 E:662 ||| JJ
types  ||| S:662 E:668 ||| NNS
of  ||| S:668 E:671 ||| IN
course  ||| S:671 E:678 ||| NN
of  ||| S:678 E:681 ||| IN
schizophrenia  ||| S:681 E:695 ||| NN
and  ||| S:695 E:699 ||| CC
schizophrenia  ||| S:699 E:713 ||| JJ
spectrum  ||| S:713 E:722 ||| NN
disorders  ||| S:722 E:732 ||| NNS
and  ||| S:732 E:736 ||| CC
hence ||| S:736 E:741 ||| RB
,  ||| S:741 E:743 ||| ,
good  ||| S:743 E:748 ||| JJ
and  ||| S:748 E:752 ||| CC
poor  ||| S:752 E:757 ||| JJ
outcomes  ||| S:757 E:766 ||| NNS
demonstrated  ||| S:766 E:779 ||| VBD
different  ||| S:779 E:789 ||| JJ
patterns  ||| S:789 E:798 ||| NNS
of  ||| S:798 E:801 ||| IN
dynamic  ||| S:801 E:809 ||| JJ
of  ||| S:809 E:812 ||| IN
cognitive  ||| S:812 E:822 ||| JJ
decline  ||| S:822 E:830 ||| NN
during  ||| S:830 E:837 ||| IN
the  ||| S:837 E:841 ||| DT
follow-up ||| S:841 E:850 ||| JJ
.  ||| S:850 E:852 ||| .
